Augustine Osuma
10Patents
2h-index
55Co-inventors
49Inventor score
Filing activity: Nov 2, 2011 → Dec 22, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10280184B2 | Heterocyclic kinase inhibitors | Emerging Cross-Sectional Technologies | 18 | Active |
| US8609669B2 | Potassium channel modulators | Human Necessities | 5 | Active |
| US9879016B2 | Indazolones as modulators of TNF signaling | Chemistry; Metallurgy | 2 | Active |
| US9856253B2 | Tricyclic modulators of TNF signaling | Chemistry; Metallurgy | 2 | Active |
| US9187472B2 | NAMPT inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10160748B2 | Indazolones as modulators of tnf signaling | Chemistry; Metallurgy | 0 | Active |
| US9567339B2 | Primary carboxamides as BTK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10273238B2 | Indazolones as modulators of TNF signaling | Chemistry; Metallurgy | 0 | Active |
| US10266532B2 | Tricyclic modulators of TNF signaling | Chemistry; Metallurgy | 0 | Active |
| US9193723B2 | NAMPT inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.